Cargando…
Identification and assessment of TCR-T cells targeting an epitope conserved in SARS-CoV-2 variants for the treatment of COVID-19
BACKGROUND: Coronavirus disease 2019 (COVID-19) continues to be a major global public health challenge, with the emergence of variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Current vaccines or monoclonal antibodies may not well be protect against infection with new SARS-Co...
Autores principales: | Ma, Yipeng, Liu, Fenglan, Li, Bin, Peng, Kaiqi, Zhou, Hong, Xu, You, Qiao, Dongjuan, Deng, Lijuan, Tian, Geng, Nielsen, Morten, Wang, Mingjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515335/ https://www.ncbi.nlm.nih.gov/pubmed/36201943 http://dx.doi.org/10.1016/j.intimp.2022.109283 |
Ejemplares similares
-
An efficient method to identify virus-specific TCRs for TCR-T cell immunotherapy against virus-associated malignancies
por: Chen, Lei, et al.
Publicado: (2021) -
Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment
por: Zhou, Hong, et al.
Publicado: (2023) -
Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants
por: Meyer, Saskia, et al.
Publicado: (2023) -
CoV2-TCR: A web server for screening TCR CDR3 from TCR immune repertoire of COVID-19 patients and their recognized SARS-CoV-2 epitopes
por: Jian, Xingxing, et al.
Publicado: (2023) -
Treatment of metastatic non-small cell lung cancer with NY-ESO-1 specific TCR engineered-T cells in a phase I clinical trial: A case report
por: Xia, Yan, et al.
Publicado: (2018)